Golgi alkalinization by the papillomavirus E5 oncoprotein

Journal of Cell Biology

Volumn 148, Issue 2, 2000, Pages 305-315

  Schapiro, Florencia ^a,b   Sparkowski, Jason ^c   Adduci, Alex ^c   Suprynowicz, Frank ^c   Schlegel, Richard ^c   Grinstein, Sergio ^a,b,d  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Cholera toxin; pH regulation; Proton pump; V ATPase; Vesicular traffic

Indexed keywords

CHOLERA TOXIN; ONCOPROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTON PUMP; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ALKALINIZATION; ANIMAL CELL; ARTICLE; CELL PH; CONTROLLED STUDY; ENZYME ACTIVITY; GENE MUTATION; GENETIC TRANSFECTION; GOLGI COMPLEX; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; VIRUS CELL TRANSFORMATION;

3T3 CELLS; ALKALIES; AMINO ACID SEQUENCE; ANIMALS; ANTI-BACTERIAL AGENTS; BOVINE PAPILLOMAVIRUS 1; BUFFERS; CELL TRANSFORMATION, NEOPLASTIC; GOLGI APPARATUS; HYDROGEN-ION CONCENTRATION; MACROLIDES; MICE; MOLECULAR SEQUENCE DATA; MUTATION; ONCOGENE PROTEINS, VIRAL; PERMEABILITY; PHOSPHORYLATION; PROTON-TRANSLOCATING ATPASES; RECOMBINANT PROTEINS; TRANSFECTION; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 0034707669     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.148.2.305     Document Type: Article

References (47)

1. Adduci, A., and R. Schlegel. 1999. The transmembrane domain of the E5 oncoprotein contains functionally-discrete helical faces. J. Biol. Chem. 274: 10249-10258.
2. Anderson, R.G., J.R. Falck, J.L. Goldstein, and M.S. Brown. 1984. Visualization of acidic organelles in intact cells by electron microscopy. Proc. Natl Acad. Sci. USA. 81:4838-4842.
3. +-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein. J. Biol. Chem. 270:6830-6837.
4. Band, V., D. Zajchowski, V. Kulesa, and R. Sager. 1990. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc. Natl. Acad. Sci. USA. 87:463-467.
5. Beckers, J.M., and J.E. Rothman. 1992. Transport between Golgi cisternae. Methods Enzymol. 219:5-12.
6. Bowman, E.J., A. Siebers, and K. Altendorf. 1988. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc. Natl. Acad. Sci. USA. 85:7972-7976.
7. Burkhardt, A., M. Willingham, C. Gay, K.T. Jeang, and R. Schlegel. 1989. The E5 oncoprotein of bovine papillomavirus is oriented asymmetrically in Golgi and plasma membranes. Virology. 170:334-339.
8. Chen, S.-L., T.-C. Tsai, C.-P. Han, and Y.-P. Tsao. 1996. Mutational analysis of papillomavirus type 11 E5a oncoprotein. J. Virol. 70:3502-3508.
9. Conrad, M., V.J. Bubb, and R. Schlegel. 1993. The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein. J. Virol. 67:6170-6178.
10. Drummond-Barhosa, D.A., R.R. Vaillancourt, A. Kazlauskas, and D. DiMaio, 1995. Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Mol. Cell. Biol. 15:2570-2581.
11. Eisner, D.A., N.A. Kenning, S.C. O'Neill, G. Pocock, C.D. Richards, and M. Valdeolmillos. 1989. A novel method for absolute calibration of intracellular pH indicators. Pflugers. Arch. 413:553-558.
12. Fambrough, D., K. McClure, A. Kazlauskas, and E.S. Lander. 1999. Diverse signalling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell. 97:727-741.
13. Forgac, M. 1989. Structure and function of vacuolar class of ATP-driven proton pumps. Physiol. Rev. 69:765-796.
14. +)-ATPase. J. Bioenerg. Biomembr. 24:341-350.
15. Goldstein, D.J., and R. Schlegel. 1990. The E5 oncoprotein of bovine papillomavirus binds to a 16 kD cellular protein. EMBO (Eur. Mol. Biol. Organ.) J. 9:137-145.
16. +-ATPases. Nature. 352:347-349.
17. Goldstein, D.J., T. Andresson, J.J. Sparkowski, and R. Schlegel. 1992a. The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions. EMBO (Eur. Mol. Biol. Organ.) J. 11:4851-4859.
18. +-ATPase. J. Virol. 66:405-413.
19. Goldstein, D.J., W. Li, L.M. Wang, M.A. Heidaran, S. Aaronson, R. Shinn, R. Schlegel, and J.H. Pierce. 1994. The bovine papillomavirus type I E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation. J. Virol. 68:4432-4141.
20. Horwitz, B.H., A.L. Burkhardt, R. Schlegel, and D. DiMaio. 1988. 44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-lerminal aminci acids. Mol. Cell. Biol. 8:4071-4078.
21. Kim, J.H. C.A. Lingwood, D.B. Williams, W. Furuya, M.Y. Manolson, and S. Grinstein. 1996. Dynamic measurement of the pH of the Golgi complex in living cells using retrograde transport of the verotoxin receptor. J. Cell Biol. 134:1387-1399.
22. Kneen, M., J. Farinas, Y. Li, and A.S. Verkman. 1998. Green fluorescent protein as a noninvasive intracellular pH indicator. Biophys. J. 74:1591-1599.
23. Leptak, C., S. Ramon y Cajal, R. Kulke, B.H. Horwitz, D.J. Riese II, G.P. Dotto, and D. DiMaio. 1991. Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16. J. Virol. 65:7078-7083.
24. Llopis, J., J.M. McCaffery, A. Miyawaki, M.G. Farquhar, and R.Y. Tsien. 1998. Measurement of cytosolic, mitochondrial, and Golgi pH in single living cells with green fluorescent proteins. Proc. Natl. Acad. Sci. USA. 95:6803-6808.
25. Lowe, A., and O. al-Awqati. 1988. Proton ATPases in Golgi vesicles and endoplasmic reticulum: characterization and reconstitution of proton pumping. Methods Enzymol. 157:611-619.
26. +-ATPases. Proc. Natl. Acad. Sci. USA. 85:5521-5524.
27. Martin, P., W.C. Vass, J.T. Schiller, D.R. Lowy, and T.J. Velu. 1989. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors. Cell. 59:21-32.
28. +-ATPase and its suhunit structures. J. Biol. Chem. 264:18445-18450.
29. +-ATPase. Proc. Natl. Acad. Sci. USA. 88:1938-1942.
30. Orth, G. 1987. Epidermodysplasia verruciformis. In The Papovaviridae. N.P. Salzman and P.M. Howley, editors. Plenum Press, New York. 199-243.
31. Petti, L. and D. DiMaio. 1992. Stable association between the bovine papillomavirus E5 transforming protein and activated platelet-derived growth factor receptor in transformed mouse cells. Proc. Natl. Acad. Sci. USA. 89: 6736-6740.
32. Petti, L., and D. DiMaio. 1994. Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells. J. Virol. 68: 3582-3592.
33. Petti, L., L.A. Nilson, and D. DiMaio. 1991. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO (Eur. Mol. Biol. Organ.) J. 10:845-855.
34. Pinto, L.H., L.J. Holsinger, and R.A. Lamb. 1992. Influenza virus M2 protein has ion channel activity. Cell. 69:517-528.
35. Roos, A., and W.F. Boron. 1981. Intracellular pH. Physiol. Rev. 61:296-434.
36. Schapiro, F.B., C. Lingwood, W. Furuya, and S. Grinstein. 1998. pH-independent retrograde targeting of glycolipids to the Golgi complex. Am. J. Physiol. 274:C319-C332.
37. Schlegel, R., M. Wade-Glass, M.S. Rabson, and Y.C. Yang. 1986. The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. Science. 233:464-467.
38. Seksek, O., J. Biwersi, and A.S. Verkman. 1995. Evidence against defective trans-Golgi acidification in cystic librosis. J Biol. Chem. 270:4967-4970.
39. Sparkowski, J., J. Anders, and R. Schlegel. 1994. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. J. Virol. 68:6120-6123.
40. Sparkowski, J., J. Anders, and R. Schlegel. 1995. E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells. EMBO (Eur. Mol. Biol. Organ.) J. 14:3055-3063.
41. Sparkowski, J., M. Mense, J. Anders, and R. Schlegel. 1996. E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation. J Virol. 70:2420-2430.
42. Straight, S.W., P.M. Hinkle, R.J. Jewers, and D.J. McCance. 1993. The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes. J. Virol. 67:4521-4532.
43. Straight, S.W., B. Herman, and D.J. McCance. 1995. The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes. J. Virol. 69:3185-3192.
44. Sugrue, R.J., and A.J. Hay. 1991. Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a letrameric channel. Virology. 180:617-624.
45. Sun, S.Z., X.S. Xie, and D.K. Stone. 1987. Isolation and reconstitution of the dicyclohexylcarbodiimide-sensitive proton pore of the clathrin-coated vesicle proton translocating complex. J. Biol. Chem. 262:14790-14794.
46. zur Hausen, H. 1989. Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers. Cancer Res. 49:4677-4681.
47. zur Hausen, H., and A. Schneider. 1987. The role of papillomaviruses in human anogenital cancer. In The Papovaviridae. N.P. Salzman & P.M. Howley, editors. New York, NY. Plenum Press. 245-263.